Infection Control for the OB/GYN Surgeon

advertisement

Infection Control for the OB/GYN

Surgeon

Gonzalo Bearman, MD, MPH

Assistant Professor of Internal Medicine &

Epidemiology

Associate Hospital Epidemiologist

Outline

• Nosocomial Infections are a significant cause of morbidity and mortality

• There has been increased public interest in nosocomial infections

• Shifting paradigm

– Many infections are preventable

• SSI and OB/GYN

– Surveillance data

– Risk factors

– Modifiable risk factors- modifiable interventions

• BSI and OB/GYN

– Surveillane

– Risk reduction strategies

• Proliferation of drug resistant nosocomial pathogens

– Hand Hygeiene and Contact precautions

“11,600 patients got infections in Pa. hospitals “

7/13/2005

"The consequences clearly are huge," says Marc

Volavka, executive director of the Pennsylvania Health

Care Cost Containment

Council, an independent state agency that published the data. "Everyone is paying the bill."

Hospital-acquired infections reported by

Pennsylvania hospitals in 2004:

Infection Number

Urinary tract

Bloodstream

6,139

1,932

Pneumonia

Surgical site

1,335

1,317

Multiple infections 945

Total 11,668

Source: Pennsylvania Health Care Cost Containment

Council

U.S. News and World Report, July 18, 2005.

Shifting Vantage Points on

Nosocomial Infections

Many infections are inevitable, although some can be prevented

Each infection is potentially preventable unless proven otherwise

Gerberding JL. Ann Intern Med 2002;137:665-670 .

Nosocomial Infections

• 5-10% of patients admitted to acute care hospitals acquire infections

– 2 million patients/year

– ¼ of nosocomial infections occur in ICUs

– 90,000 deaths/year

– Attributable annual cost: $4.5 – $5.7 billion

• Cost is largely borne by the healthcare facility not 3 rd party payors

Weinstein RA. Emerg Infect Dis 1998;4:416-420.

Jarvis WR. Emerg Infect Dis 2001;7:170-173.

Nosocomial Infections

• 70% are due to antibiotic-resistant organisms

• Invasive devices are more important than underlying diseases in determining susceptibility to nosocomial infection

Burke JP. New Engl J Med 2003;348:651-656.

Safdar N et al. Current Infect Dis Reports 2001;3:487-495.

Attributable Costs of Nosocomial

Infections

Cost per Infection

Wound infections $3,000 - $27,000

Sternal wound infection $20,000 - $80,000

Catheter-associated

BSI

Pneumonia

$5,000 - $34,000

$10,000 - $29,000

Urinary tract infection $700

Nettleman M. In: Wenzel RP, ed. Prevention and Control of Nosocomial Infections,

4 th ed. 2003:36.

Major Sites of Nosocomial

Infections

• Urinary tract infection

• Bloodstream infection

• Pneumonia (ventilator-associated)

• Surgical site infection

Surgical Site Infections in

Obstetrics and Gynecology

National Nosocomial Infections

Surveillance System (NNIS)

• NNIS is the only national system for tracking

HAIs

• Voluntary reporting system has approximately

300 hospitals

• The NNIS database uses standardized definitions of HAI’s to:

– Describe the epidemiology of HAIs

– Describe antimicrobial resistance associated with

HAIs

– Produce aggregated HAI rates suitable for interhospital comparison http://www.cdc.gov/ncidod/hip/SURVEILL/NNIS.HTM

National Nosocomial Infections

Surveillance System (NNIS)

Classification

Clean

Clean-contaminated:

GI/GU tracts entered in a controlled manner

Contaminated: open, fresh, traumatic wounds infected urine, bile gross spillage from GI tract

Dirty-infected:

Wound Class

0

1

2

3

SSI Risk

Lower

Higher

NNIS- SSI Surveillance 1992-2004

Abdominal Hysterectomy

Risk Index Number of hospitals

Pooled mean rate

Per 100 operations

0 107 1.36

1 100 2.32

2,3 53 5.17

Median- 50% percentile

0.91

1.96

4.21

Am J Infect Control 2004;32:470-85

NNIS- SSI Surveillance 1992-2004

Vaginal Hysterectomy

Risk Index Number of hospitals

Pooled mean rate

Per 100 operations

Median-

50% percentile

0,1,2,3 71 1.31

0.91

Am J Infect Control 2004;32:470-85

NNIS- SSI Surveillance 1992-2004

0

1

Cesarean Section

Risk Index Number of hospitals

Pooled mean rate

Per 100 operations

2,3

130

117

51

2.71

4.14

7.53

Median-

50% percentile

2.17

3.19

5.38

Am J Infect Control 2004;32:470-85

Hospital Morbidity Due to Post-operative

Infections in Obstetrics and Gynecology

• Post operative infections prospectively surveyed from 1997-1998 in tertiary care medical center, Bahrain

– Definition of postoperative infection:

• Fever

• Purulent discharge from wound

– With or without a positive microbiologic culture

• Re-admissions for wound infections were not included in the study

Saudi Medical Journal 2000: Vol 21 (3) 270-273

Hospital Morbidity Due to Post-operative

Infections in Obstetrics and Gynecology

Type of operation

(%)

No. of

Operations

(%)

Cesarean section

Major

Gynecologic

Surgery

2193

1839

Wound

Infection alone (%)

35 (2)

9 (0.4)

Fever alone

(%)

Both wound

Infection and

Fever (%)

30 (1)

5 (0.3)

7 (0.3)

4 (0.2)

Total 4032 35 (0.9) 35 (0.9) 11(0.3)

Saudi Medical Journal 2000: Vol 21 (3) 270-273

Hospital Morbidity Due to Post-operative

Infections in Obstetrics and Gynecology

Number of Isolates Organism

Gram Positive

• S.aureus

S.epidermidis

• Streptococci

Enterococci

Gram Negative

• Enterbacter

Klebsiella

• E.coli

Proteus

• P.aeruginosa

Acinetobacter

Gram negative bacilli

Candida

Total

3 (3)

13 (14)

6(6)

19 (20)

4(4)

14(15)

11(12)

9(10)

8(8.5)

1(1)

1(1)

5(5)

94

Genitourinary flora is a significant source of contamination during surgery

Saudi Medical Journal 2000: Vol 21 (3) 270-273

Risk Factors for Surgical Site Infections

Following Cesarean Section

• OBJECTIVE: To identify risk factors associated with surgical-site infections (SSIs) following cesarean sections.

• DESIGN: Prospective cohort study.

• SETTING: High-risk obstetrics and neonatal tertiary-care center in upstate New York.

• METHODS:

• Prospective surgical-site surveillance was conducted using methodology of the National Nosocomial

Infections Surveillance System.

• Infections were identified on admission, within 30 days following the cesarean section, by readmission to the hospital or by a postdischarge survey.

• Multiple logistic-regression analysis used for risk factor identification

Infect Control Hosp Epidemiol. 2001 Oct;22(10):613-7

Risk Factors for Surgical Site Infections

Following Cesarean Section

Multiple logistic-regression analysis

Risk Factor Odds Ratio/ 95% CI/ P value

2.63; 1.50-4.6; P=.008

Absence of antibiotic prophylaxis

Length surgery

<7 prenatal visits

Duration of ruptured membranes

1.01; 1.00-1.02; P=.04

3.99; 1.74-9.15; P=.001

1.02; 1.01-1.03; P=.04

Infect Control Hosp Epidemiol. 2001 Oct;22(10):613-7

Summary: SSI’s in OB/GYN

• NNIS- SSIs are reported to occur in 1%-

7% of OB/GYN surgeries

• SSI are typically caused by maternal cutaneous or endometrial/vaginal flora

• When an exogenous source is the cause of SSI in the obstetrical patient,

S.aureus

is frequently implicated

Preventing Surgical Site Infections

Focus on modifiable risk factors

Sources of SSIs

• Endogenous: patient’s skin or mucosal flora

– Increased risk with devitalized tissue, fluid collection, edema, larger inocula

• Exogenous

– Includes OR environment/instruments, OR air, personnel

• Hematogenous/lymphatic: seeding of surgical site from a distant focus of infection

– May occur days to weeks following the procedure

• Most infections occur due to organisms implanted during the procedure

Up to 20% of skin-associated bacteria in skin appendages (hair follicles, sebaceous glands) & are not eliminated by topical antisepsis. Transection of these skin structures by surgical incision may carry the patient's resident bacteria deep into the wound and set the stage for subsequent infection.

Downloaded from: Principles and Practice of Infectious Diseases

© 2004 Elsevier

Risk Factors for SSI

• Duration of pre-op hospitalization

* increase in endogenous reservoir

• Pre-op hair removal

* esp if time before surgery > 12 hours

* shaving>>clipping>depilatories

• Duration of operation

*increased bacterial contamination

* tissue damage

* suppression of host defenses

* personnel fatigue

SCIP

• A national partnership of organizations to improve the safety of surgical care by reducing post-operative complications through a national campaign

• Goal: reduce the incidence of surgical complications by 25 percent by the year 2010

• Initiated in 2003 by the Centers for Medicare &

Medicaid Services (CMS) & the Centers for Disease

Control & Prevention (CDC)

– Steering committee of 10 national organizations

– More than 20 additional organizations provide technical expertise

Putting risk reduction guidelines into practice

SCIP Steering Committee

Organizations

• Agency for Healthcare Research and Quality

• American College of Surgeons

• American Hospital Association

• American Society of Anesthesiologists

• Association of periOperative Registered Nurses

• Centers for Disease Control and Prevention

• Centers for Medicare & Medicaid Services

• Department of Veterans Affairs

• Institute for Healthcare Improvement

• Joint Commission on Accreditation of Healthcare

Organizations

SCIP Performance Measures

Surgical infection prevention

• SSI rates

• Appropriate prophylactic antibiotic chosen

• Antibiotic given within 1 hour before incision

• Discontinuation of antibiotic within 24 hours of surgery

• Glucose control

• Proper hair removal

• Normothermia in colorectal surgery patients

Monetary incentives for promoting quality and compliance with SSI risk reduction guidelines:

March 12, 2005

In recent years, the healthcare industry has placed a stronger emphasis on reducing medical errors, monitoring everything from how long doctors sleep to whether or not their handwriting is legible.

Now one organization is not only recognizing the hospitals that follow patient safety and clinical guidelines, but rewarding them for doing so. Anthem Blue Cross and Blue Shield recently gave a total of $6 million to 16 Virginia hospitals as part of the company's new Quality-In-Sights Hospital Incentive Program

(Q-HIP).

http:// www.richmond.com

ID=15

Downloaded from: Principles and Practice of Infectious Diseases

Process Indicators:

Appropriate Antibiotic Prophylaxis

Procedure Approved Antibiotics

Hysterectomy

•Cefazolin

•Cefoxitin

Approved for β-lactam allergy

•Clindamycin + gentamicin

•Clindamycin + levofloxacin

•Metronidazole + gentamicin

•Metronidazole + levofloxacin

•Clindamycin

Process Indicators:

Duration of Antimicrobial Prophylaxis

Prophylactic antimicrobials should be discontinued within 24 hrs after the end of surgery

Bratzler DW et al. Clin Infect Dis 2004;38:1706-15.

Process Indicators:

Timing of First Antibiotic Dose

Infusion should begin within 60 minutes of the incision

Bratzler DW et al. Clin Infect Dis 2004;38:1706-15.

Nosocomial Bloodstream Infections

Nosocomial Bloodstream Infections,

1995-2002

Rank Pathogen Percent

N= 24,847

52 BSI/10,000 admissions

5

6

7

3

4

8

9

1

2

Coagulase-negative Staph

S. aureus

Enterococci

Candida spp

E. coli

Klebsiella spp

Pseudomonas aeruginosa

Enterobacter spp

Serratia spp

10 Acinetobacter spp

31.3%

20.2%

9.4%

9.0%

5.6%

4.8%

4.3%

3.9%

1.7%

1.3%

Edmond M. SCOPE Project .

Nosocomial Bloodstream Infections,

1995-2002

Obstetrics and Gynecology

N= 24,847

52 BSI/10,000 admissions

•Proportion of all BSI 0.9% (n=209)

• E.coli (33%)

• S.aureus ( 11.7%)

• Enterococci (11.7)

In obstetrics, BSIs are uncommon.

However, the principal pathogen is

E.coli and not coagulase negative staphylococci.

The source is typically genitourinary

Edmond M. SCOPE Project .

Nosocomial Bloodstream Infections

• 12-25% attributable mortality

• Risk for bloodstream infection:

BSI per 1,000 catheter/days

Subclavian or internal jugular CVC 5-7

Hickman/Broviac (cuffed, tunneled)

PICC

1

0.2 - 2.2

Risk Factors for Nosocomial BSIs

• Heavy skin colonization at the insertion site

• Internal jugular or femoral vein sites

• Duration of placement

• Contamination of the catheter hub

Prevention of Nosocomial BSIs

• Coated catheters

– In meta-analysis C/SS catheter decreases BSI

(OR 0.56, CI95 0.37-0.84)

– M/R catheter may be more effective than C/SS

– Disadvantages: potential for development of resistance; cost (M/R > C/SS > uncoated)

• Use of heparin

– Flushes or SC injections decreases catheter thrombosis, catheter colonization & may decrease BSI

Prevention of Nosocomial BSIs

• Limit duration of use of intravascular catheters

– No advantage to changing catheters routinely

• Change CVCs to PICCs when possible

• Maximal barrier precautions for insertion

– Sterile gloves, gown, mask, cap, full-size drape

– Moderately strong supporting evidence

• Chlorhexidine prep for catheter insertion

30%-40% of all Nosocomial

Infections are Attributed to

Cross Transmission-

Implication For The Spread

Drug Resistant Pathogens

NNIS: Selected antimicrobial resistant pathogens associated with HAIs

Fig 1. Selected antimicrobial-resistant pathogens associated with nosocomial infections in

ICU patients, comparison of resistance rates from January through December 2003 with

1998 through 2002, NNIS System.

Am J Infect Control 2004;32:470-85

Antimicrobial Resistant

Pathogens of Ongoing Concern

• Vancomycin resistant enterocci

– 12% increase in 2003 when compared to 1998-2002

• MRSA

– 12% increase in 2003 when compared to 1998-2002

– Increased reports of Community-Acquired MRSA

• Cephalosporin and Imipenem resistant gram negative rods

– Klebsiella pneumonia

Pseudomonas aeruginosa

Am J Infect Control 2004;32:470-85

Transfer of VRE via HCW Hands

16 transfers (10.6%) occurred in 151 opportunities.

13 transfers occurred in rooms of unconscious patients who were unable to spontaneously touch their immediate environment

Duckro et al. Archive of Int Med. Vol.165,2005

The inanimate environment is a reservoir of pathogens

X represents a positive Enterococcus culture

The pathogens are ubiquitous

~ Contaminated surfaces increase cross-transmission ~

Abstract: The Risk of Hand and Glove Contamination after Contact with a VRE (+) Patient Environment. Hayden M, ICAAC, 2001, Chicago, IL.

Community-associated methicillinresistant Staphylococcus aureus in hospital nursery and maternity units.

• Outbreak of 7 cases of skin and soft tissue infections due to a strain of CA-MRSA.

– All patients were admitted to the labor and delivery, nursery, or maternity units during a 3-week period.

– Genetic fingerprinting showed that the outbreak strain was closely related to the

USA 400 strain that includes the midwestern strain MW2

Emerg Infect Dis. 2005 Jun;11(6):808-13 .

Table 1. Clinical information for patients with methicillin-resistant Staphylococcus aureus infection during the outbreak period

Patient

Age at onset Sex Strain Infection type Initial therapy Definitive therapy

P1, newborn

P2, newborn

P3, mother

P4, newborn

P5, newborn

P6, newborn

P7, newborn

P8, mother

8 d

13 d

33 y

2 d

4 d

2 d

1 d

24 y

F USA 400

F USA 400

F USA 400

Preseptal cellulitis

Omphalitis, otitis externa

Breast abscess

Nafcillin, cefotaxime

Ampicillin, cefotaxime

Cefazolin

M USA 400 Omphalitis, pustulosis Nafcillin Gentamicin

M USA 400

M USA 400

Pustulosis

Pustulosis

F

F

USA 400

Unique

Pustulosis, mastitis

Peripheral IV catheter site

Cephalexin

None

Topical mupirocin

Cefazolin

Topical gentamicin

Topical mupirocin

Surgical drainage, vancomycin, topical mupirocin

Gentamicin, topical mupirocin

Topical bacitracin

Local wound care

Vancomycin

Trimethoprim-sulfamethoxazole, catheter removal

Emerg Infect Dis. 2005 Jun;11(6):808-13.

Epidemic of Staphylococcus aureus nosocomial infections resistant to methicillin in a maternity ward

• Seventeen cases were recorded over a nineweek period (two cases per week).

– All were skin and soft tissue infections

• Pulsed field gradient gel electrophoresis confirmed the clonal character of the strain.

• No definite risk factors were determined by a case-control study.

• Environmental factors were considered key in the persistence of this MRSA outbreak.

Pathol Biol (Paris). 2001 Feb;49(1):16-22.

The inanimate environment is a reservoir of pathogens

Recovery of MRSA, VRE, C.

diff CNS and GNR

Devine et al. Journal of Hospital Infection. 2001;43;72-75

Lemmen et al Journal of Hospital Infection. 2004; 56:191-197

Trick et al. Arch Phy Med Rehabil Vol 83, July 2002

Walther et al. Biol Review, 2004:849-869

The inanimate environment is a reservoir of pathogens

Recovery of MRSA, VRE, CNS. C.

diff and GNR

Devine et al. Journal of Hospital Infection. 2001;43;72-75

Lemmen et al Journal of Hospital Infection. 2004; 56:191-197

Trick et al. Arch Phy Med Rehabil Vol 83, July 2002

Walther et al. Biol Review, 2004 :849-869

The inanimate environment is a reservoir of pathogens

Recovery of MRSA, VRE, CNS. C.

diff and GNR

Devine et al. Journal of Hospital Infection. 2001;43;72-75

Lemmen et al Journal of Hospital Infection. 2004; 56:191-197

Trick et al. Arch Phy Med Rehabil Vol 83, July 2002

Walther et al. Biol Review, 2004:849-869

Alcohol based hand hygiene

Quick

solutions

Easy to use

Very effective antisepsis due to bactericidal properties of alcohol

Hand Hygiene

• Single most important method to limit cross transmission of nosocomial pathogens

• Multiple opportunities exist for HCW hand contamination

– Direct patient care

– Inanimate environment

• Alcohol based hand sanitizers are ubiquitous

– USE THEM BEFORE AND AFTER PATIENT

CARE ACTIVITIES

Contact

Precautions for drug resistant pathogens.

Gowns and gloves must be worn upon entry into the patient’s room

Conclusion

• Nosocomial Infections are a significant causes of morbidity and mortality

• There has been increased public interest in nosocomial infections- this will likely result in greater compliance with IC guidelines

• Shifting paradigm

– Many infections are preventable

• SSI and OB/GYN

– 1-7 % of all OB/GYN procedures (NNIS)

– Increased scrutiny of compliance with risk reduction intervention

– Preoperative antibiotics: choice, timing, discontinuation;

• BSI and OB/GYN

– BSI is less common than in Medicine/Surgical services

– Risk reduction strategies should include appropriate use and prompt removal of invasive devices

• Proliferation of drug resistant nosocomial pathogens

– Importance of Hand Hygiene and Contact precautions

Download